MR Elastography of Cognitive Impairment
NCT06029114 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2026-01-13
Summary
The purpose of this research is to further investigate the potential of brain stiffness as a novel biomarker for Alzheimer's disease.
Conditions
- Alzheimer Disease
- Mild Cognitive Impairment
- Healthy
Interventions
- DIAGNOSTIC_TEST
-
Magnetic Resonance Elastography (MRE)
Imaging technique performed on a Compact 3T MRI scanner that measures the stiffness (mechanical properties) of tissues.
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH - lead OTHER
Principal Investigators
-
John Huston, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-11
- Primary Completion
- 2027-11-30
- Completion
- 2027-11-30
Countries
- United States
Study Locations
More Related Trials
-
Functional MRI Biomarkers of Cognitive Decrements in Diabetes
NCT01705210 ·Status: COMPLETED
-
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)
NCT03702816 ·Status: TERMINATED ·Phase: PHASE2
-
The DIAGNOSE CTE Research Project-II
NCT06860828 ·Status: ENROLLING_BY_INVITATION
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Magnetic Resonance Imaging Studies of Motor and Thought Processes
NCT00001361 ·Status: COMPLETED
-
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
NCT04680130 ·Status: ENROLLING_BY_INVITATION
-
Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults
NCT01609335 ·Status: COMPLETED ·Phase: PHASE1
-
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
NCT03362658 ·Status: ACTIVE_NOT_RECRUITING
-
Neuroimaging Study
NCT03618186 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Technical Development of Multi-Parametric Renocerebral MRI
NCT02831335 ·Status: RECRUITING
-
Biomarkers and Early Alzheimer's Disease
NCT00094952 ·Status: UNKNOWN
-
Infiltration of Gadolinium Injection in Brain MR Scans Using Artificial Intelligence
NCT05235646 ·Status: COMPLETED
-
A Composite MR Neuroimaging Marker for Alzheimer's Disease
NCT01615666 ·Status: WITHDRAWN
-
Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype
NCT02706210 ·Status: UNKNOWN
-
the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy
NCT06245707 ·Status: UNKNOWN ·Phase: NA
-
MR-based Stroke Mechanism and Future Risk Score
NCT02580097 ·Status: COMPLETED
-
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
NCT02868684 ·Status: COMPLETED
-
Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
NCT07089303 ·Status: RECRUITING
-
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906 ·Status: RECRUITING
-
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
NCT00757939 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment
NCT03265912 ·Status: COMPLETED
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
NCT05106465 ·Status: COMPLETED
-
Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease
NCT06832839 ·Status: RECRUITING
-
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
NCT02562989 ·Status: COMPLETED ·Phase: PHASE1